These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathology in practice. Mast cell tumor (MCT) of the oral mucosa with submandibular lymph node metastasis in a dog. Pabilonia KL; Podell BK; Powers BE J Am Vet Med Assoc; 2013 Sep; 243(6):795-7. PubMed ID: 24004225 [No Abstract] [Full Text] [Related]
3. Incorporation of sentinel lymph node mapping in dogs with mast cell tumours: 20 consecutive procedures. Worley DR Vet Comp Oncol; 2014 Sep; 12(3):215-26. PubMed ID: 22958227 [TBL] [Abstract][Full Text] [Related]
4. Biological behavior of oral and perioral mast cell tumors in dogs: 44 cases (1996-2006). Hillman LA; Garrett LD; de Lorimier LP; Charney SC; Borst LB; Fan TM J Am Vet Med Assoc; 2010 Oct; 237(8):936-42. PubMed ID: 20946081 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of prognostic indicators in dogs with multiple, simultaneously occurring cutaneous mast cell tumours: 63 cases. O'Connell K; Thomson M Vet Comp Oncol; 2013 Mar; 11(1):51-62. PubMed ID: 22235766 [TBL] [Abstract][Full Text] [Related]
6. Comparison of mitotic index and Ki67 index in the prognostication of canine cutaneous mast cell tumours. Berlato D; Murphy S; Monti P; Stewart J; Newton JR; Flindall A; Maglennon GA Vet Comp Oncol; 2015 Jun; 13(2):143-50. PubMed ID: 23489679 [TBL] [Abstract][Full Text] [Related]
7. Canine subcutaneous mast cell tumor: characterization and prognostic indices. Thompson JJ; Pearl DL; Yager JA; Best SJ; Coomber BL; Foster RA Vet Pathol; 2011 Jan; 48(1):156-68. PubMed ID: 21078881 [TBL] [Abstract][Full Text] [Related]
8. Weishaar's classification system for nodal metastasis in sentinel lymph nodes: Clinical outcome in 94 dogs with mast cell tumor. Stefanello D; Gariboldi EM; Boracchi P; Ferrari R; Ubiali A; De Zani D; Zani DD; Grieco V; Giudice C; Recordati C; Caniatti M; Auletta L; Chiti LE J Vet Intern Med; 2024; 38(3):1675-1685. PubMed ID: 38426589 [TBL] [Abstract][Full Text] [Related]
9. Additional information on the behavior of oral mast cell tumors. Hoffman S J Am Vet Med Assoc; 2010 Dec; 237(12):1368. PubMed ID: 21229804 [No Abstract] [Full Text] [Related]
10. Validation of the prognostic value of histopathological grading or c-kit mutation in canine cutaneous mast cell tumours: a retrospective cohort study. Takeuchi Y; Fujino Y; Watanabe M; Takahashi M; Nakagawa T; Takeuchi A; Bonkobara M; Kobayashi T; Ohno K; Uchida K; Asano K; Nishimura R; Nakayama H; Sugano S; Ohashi Y; Tsujimoto H Vet J; 2013 Jun; 196(3):492-8. PubMed ID: 23384436 [TBL] [Abstract][Full Text] [Related]
11. Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Welle MM; Bley CR; Howard J; Rüfenacht S Vet Dermatol; 2008 Dec; 19(6):321-39. PubMed ID: 18980632 [TBL] [Abstract][Full Text] [Related]
12. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours. Kiupel M; Webster JD; Miller RA; Kaneene JB J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909 [TBL] [Abstract][Full Text] [Related]
13. Cytologic comparison of the percentage of mast cells in lymph node aspirate samples from clinically normal dogs versus dogs with allergic dermatologic disease and dogs with cutaneous mast cell tumors. Mutz ML; Boudreaux BB; Royal A; Merchant S; Pucheu-Haston C; Griffith EH; Gieger TL J Am Vet Med Assoc; 2017 Aug; 251(4):421-428. PubMed ID: 28763275 [TBL] [Abstract][Full Text] [Related]
14. Breed related odds ratio and anatomic distribution of canine mast cell tumours in Austria. Retrospective study of cases in the years 2000-2010. Leidinger EF; Freeman K; Kirtz G; Hooijberg EH; Sick K Tierarztl Prax Ausg K Kleintiere Heimtiere; 2014; 42(6):367-73. PubMed ID: 25418504 [TBL] [Abstract][Full Text] [Related]
15. Is lymph node metastasis of canine grade 2 MCTs justification for adjuvant therapy? Schulman FY Vet Comp Oncol; 2015 Jun; 13(2):151. PubMed ID: 25968074 [No Abstract] [Full Text] [Related]
16. In situ c-KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors. Seung BJ; Cho SH; Kim SH; Bae MK; Lim HY; Sur JH Vet Comp Oncol; 2021 Mar; 19(1):132-139. PubMed ID: 32926564 [TBL] [Abstract][Full Text] [Related]
17. A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors. Sabattini S; Kiupel M; Finotello R; Stefanello D; Faroni E; Bertazzolo W; Bonfanti U; Rigillo A; Del Magno S; Foglia A; Aresu L; Gambini M; Caniatti M; Marconato L BMC Vet Res; 2021 Oct; 17(1):331. PubMed ID: 34649575 [TBL] [Abstract][Full Text] [Related]
18. Epidemiological Study of Canine Mast Cell Tumours According to the Histological Malignancy Grade. Śmiech A; Ślaska B; Łopuszyński W; Jasik A; Szczepanik M; Wilkołek P Pol J Vet Sci; 2017 Sep; 20(3):455-465. PubMed ID: 29166281 [TBL] [Abstract][Full Text] [Related]
19. Patient and tumour factors influencing canine mast cell tumour histological grade and mitotic index. Reynolds BD; Thomson MJ; O'Connell K; Morgan EJ; Gummow B Vet Comp Oncol; 2019 Sep; 17(3):338-344. PubMed ID: 30891882 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of bone marrow aspirates from multiple sites for staging of canine lymphoma and mast cell tumours. Aubry OA; Spangler EA; Schleis SE; Smith AN Vet Comp Oncol; 2014 Mar; 12(1):58-66. PubMed ID: 22577893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]